Orthocell (ASX:OCC) appointed MediTime as its exclusive in-country distributor for its nerve repair product Remplir in Thailand, according to a Friday Australian bourse filing.

The company said MediTime's clinical education platform, key opinion leader (KOL) relationships, hospital access, and logistics network are expected to accelerate the engagement and adoption of Remplir throughout Thailand.

The company added that the appointment further strengthens Orthocell's expanding Asian distribution network, with product sales underway in Australia, Singapore, and Hong Kong, while the company continues to focus resources on the US market, where recent approvals have expanded access to around 336 hospitals, including 221 US military medical centers.